Metastatic liver disease and fulminant hepatic failure: Presentation of a case and review of the literature

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 11, 2003, Pages 1235-1240

  Athanasakis, Elias ^a   Mouloudi, Eleni ^a   Prinianakis, George ^a   Kostaki, Maria ^a   Tzardi, Maria ^a   Georgopoulos, Dimitrios ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Fulminant hepatic failure; Liver metastases; Multiple organ failure syndrome; Small cell lung carcinoma

Indexed keywords

AGED; AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ENDOSCOPY; HUMAN; INTENSIVE CARE; KIDNEY FAILURE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FAILURE; LIVER METASTASIS; LIVER PARENCHYMA; LUNG SMALL CELL CANCER; MALE; MULTIPLE ORGAN FAILURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; TUMOR CELL; TUMOR DIFFERENTIATION;

AGED; CARCINOMA, SMALL CELL; HUMANS; LIVER FAILURE; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; NEOPLASM INVASIVENESS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0842286970     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200311000-00014     Document Type: Review

References (57)

1. Turley K. Thoracic wall, pleura, mediastinum, and lung. In: Current Surgical Diagnosis and Treatment, 10th edition. Way LW (editor). East Norwalk, Connecticut: Appleton & Lange; 1994. pp. 317-357.
2. Minna JD. Neoplasms of the lung. In: Harrison's Principles of Internal Medicine, 12th edition. Wilson JD, Braunwald E, Isselbacher KJ, et al. (editors). New York: McGraw-Hill; 1991. pp. 1102-1110.
3. Schreve RH, Terpstra OT, Ausema L, Lameris JS, van Seijen AJ, Jeekel J. A prospective study comparing liver enzymes, scintigraphy, ultrasonography and computed tomography. Br J Surg 1984; 71:947-949.
4. Shakil AO, Mazariegos GV, Kramer DJ. Fulminant hepatic failure. Surg Clin North Am 1999; 79:77-108.
5. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993; 342:273-276.
6. Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: an assessment of King's criteria. J Hepatol 1997; 26:62-65.
7. Schiodt FV, Atillasoy E, Shakil AO, et al. Etiology and prognosis for 295 patients with acute liver failure in the US. Gastroenterology 1997; 122:A1376.
8. Watson AJ. Diffuse intra-sinusoidal metastatic carcinoma of the liver. J Pathol Bacteriol 1955; 69:207-217.
9. Rowbotham D, Wendon J, Williams R. Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases. Gut 1998; 42:576-580.
10. Sawabe M, Kato Y, Ohashi I, Kitagawa T. Diffuse intrasinusoidal metastasis of gastric carcinoma to the liver leading to fulminant hepatic failure. Cancer 1990; 65:169-173.
11. Martelli O, Coppola L, De Quarto AL, Palma M, Sarmiento R, Foggi CM. Fulminant hepatic failure caused by diffuse intrasinusoidal metastatic liver disease: a case report. Tumori 2000; 86:424-427.
12. Alcalde M, Garcia-Diaz M, Pecellin J, Pijierro A, Sanchez P, Sonia R, de Santamaria JS. Acute liver failure due to diffuse intrasinusoidal metastases of urothelial carcinoma. Acta Gastroenterol Belg 1996; 59:163-165.
13. Tas F, Aydiner A, Topuz E, Camlica H, Saip P, Eralp Y. Factors influencing the distribution of metastases and survival in extensive disease small cell lung cancer. Acta Oncol 1999; 38:1011-1015.
14. Ihara N, Yashiro N, Kinoshita T, Yoshigi J, Ouchi T, Narita M, et al. Diffuse intrasinusoidal liver metastasis of small cell lung cancer causing fulminant hepatic failure: CT findings - a case report. Radiat Med 2001; 19: 275-277.
15. Krauss EA, Ludwig PW, Sumner HW. Metastatic carcinoma presenting as fulminant hepatic failure. Am J Gastroenterol 1979; 72:651-654.
16. Harrison HB, Middleton HM III, Crosby JH, Dasher MN Jr. Fulminant hepatic failure: an unusual presentation of metastatic liver disease. Gastroenterology 1981; 80:820-825.
17. McGuire BM, Cherwitz DL, Rabe KM, Ho SB. Small-cell carcinoma of the lung manifesting as acute hepatic failure. Mayo Clin Proc 1997; 72:133-139.
18. Watanabe Y, Tanaka H, Ogawa M, Tanaka T, Tanizawa M. A case of small cell lung cancer associated with fulminant hepatitis B. Nihon Kyobu Shikkan Gakkai Zasshi 1994; 32:894-898.
19. Hwang YT, Chen PJ, Kao JH, Wang TD, Wang HH, Chu JS, et al. Rapid hepatic failure associated with a contracted liver mimicking cirrhosis in a case of nasopharyngeal carcinoma with liver metastasis. Liver 1996; 16:283-287.
20. Te HS, Schiano TD, Kahaleh M, Lissoos TW, Baker AL, Hart J, Conjeeraram HS. Fulminant hepatic failure secondary to malignant melanoma: case report and review of the literature. Am J Gastroenterol 1999; 94:262-266.
21. Fairbank WHD. Three atypical cases of Hodgkin's disease presenting with liver failure. Can Med Assoc J 1953; 69:315-317.
22. Trewby PN, Portmann B, Brinkley DM, Williams R. Liver disease as presenting manifestation of Hodgkin's disease. Q J Med 1979; 48: 137-150.
23. Lefkowitch JH, Falkow S, Whitlock RT. Hepatic Hodgkin's disease simulating cholestatic hepatitis with liver failure. Arch Pathol Lab Med 1985; 109:424-426.
24. Braude S, Gimson AE, Portmann B, Williams R. Fulminant hepatic failure in non-Hodgkin's lymphoma. Postgrad Med J 1982; 58:301-304.
25. Ghosh P, Fox IJ, Rader AM, Sorrell MF. Fulminant hepatic failure as the initial manifestation of non-Hodgkin's lymphoma. Am J Gastroenterol 1995; 90:2207-2209.
26. Woolf GM, Petrovic LM, Rojter SE, Villamil FG, Makowka L, Podesta LG, et al. Acute liver failure due to lymphoma. A diagnostic concern when considering liver transplantation. Dig Dis Sci 1994; 39:1351-1358.
27. Gargot D, Maitre F, Causse X, et al. Primary liver non-Hodgkin's lymphoma presenting as fulminant hepatic disease. Eur J Gastroenterol Hepatol 1994; 6:843-846.
28. Salo J, Nomdedeu B, Bruguera M, Ordi J, Giner P, Castells A, et al. Acute liver failure due to non-Hodgkin's lymphoma. Am J Gastroenterol 1993; 88:774-776.
29. Hess CE, Joyce RA. Acute myeloblastic leukaemia presenting as progressive hepatic failure. South Med J 1981; 74:1028-1029.
30. Zafrani ES, Leclercq B, Vernant JP, Pinandeau Y, Chomette G, Dhumeaux D. Massive blastic infiltration of the liver: a cause of fulminant hepatic failure. Hepatology 1983; 3:428-432.
31. + (helper phenotype) chronic lymphocytic leukaemia: a case report with liver failure and literature review. Med Pediatr Oncol 1988; 16: 356-362.
32. Colby TV, LaBrecque DR. Lymphoreticular malignancy presenting as fulminant hepatic disease. Gastroenterology 1982; 82:339-345.
33. Crotty CP, Winkelmann RK. Cytophagic histiocytic panniculitis with fever, cytopenia, liver failure and terminal haemorrhagic diathesis. J Am Acad Dermatol 1981; 4:181-194.
34. Beaugrand M, Trinchet JC, Callard P, Ferrier JP. Malignant histiocytosis presenting as a fulminant hepatic disease. Gastroenterology 1983; 84:447-448.
35. Lin MS, Donati RM. 'Mottled' liver scan in giant hepatomegaly due to intrasinusoidal metastasis of small cell lung cancer. Clin Nucl Med 1981; 6:496-497.
36. Smith JC. Diffuse intrasinusoidal metastatic cancer of the liver. Ann Intern Med 1961; 54:104-113.
37. Morrison WL, Pennington CR. Liver metastases from an occult breast carcinoma presenting as acute fulminant hepatic failure. Br J Clin Pract 1984; 38:273-274.
38. Schneider R, Cohen A. Fulminant hepatic failure complicating metastatic breast carcinoma. South Med J 1984; 77:84-86.
39. Razenberg PPA, Taal BG, Albus-Lutter CE. Hepatic failure due to liver metastases in breast cancer. Neth J Med 1985; 28:295-298.
40. Delpre G, Pitlik S, Halevy J, Perry G, Avidor I, Kadish U, Rosenfeld J. Intrasinusoidal metastatic melanoma of the liver with reactive hepatitis: an immunologic phenomenon? Arch Intern Med 1983; 143:363-365.
41. Bouloux PMG, Scott RJ, Goligher JE, Kindell C. Fulminant hepatic failure secondary to diffuse liver infiltration by melanoma. J R Soc Med 1986; 79:302-303.
42. Pal NR, Whittingham GE, Paley RG. Hepatic coma due to liver metastases. Br Med J 1965; i:168.
43. Eras P, Sherlock P. Hepatic coma secondary to metastatic liver disease. Ann Intern Med 1971; 74:581-583.
44. Ondreyco SM, Kjeldsberg CR, Fineman RM, Vaninetti S, Kushner JP. Monoblastic transformation in chronic myelogenous leukemia: presentation with massive hepatic involvement. Cancer 1981; 48:957-963.
45. Stein AM, Fawaz K, Tabrizi A, Blanchard R, Hou S. Multifocal malignant haemangioendothelioma presenting as acute hepatitis. A clinicopathologic study. Am J Gastroenterol 1977; 67:370-374.
46. Obara M, Satoh H, Yamashita YT, Kamma H, Ohtsuka M, Hasegawa S, Orii K. Metastatic small cell lung cancer causing biliary obstruction. Med Oncol 1998; 15:292-294.
47. Begin LR, Boucher D, Lamoureux E. Diffuse hepatic intravascular carcinomatous embolization resulting in fatal liver failure: a clinicopathologic study of 4 cases. Pathol Res Pract 2001; 197:433-440.
48. Johnson DDH, Hainsworth JD, Greco FA. Extrahepatic biliary obstruction caused by small-cell lung cancer. Ann Intern Med 1985; 102: 487-490.
49. Kotan C, Er M, Ozbay B, Uzun K, Barut I, Ozgoren E. Extrahepatic biliary obstruction caused by small-cell lung cancer: a case report. Acta Chir Belg 2001; 101:190-192.
50. Maeno T, Satoh H, Ishikawa H, Yamashita YT, Naito T, Fujiwara M, et al. Patterns of pancreatic metastasis from lung cancer. Anticancer Res 1998; 18:2881-2884.
51. Fujiwara Y, Takenaka K, Kajiyama K, Maeda T, Gion T, Shirabe K, et al. The characteristics of hepatocellular carcinoma with a high level of serum lactic dehydrogenase: a case report. Hepatogastroenterology 1997; 44:820-823.
52. Finck SJ, Giuliano AE, Morton DL. LDH and melanoma. Cancer 1982; 52:840-843.
53. Myszor MF, Record CO. Primary and secondary malignant disease of the liver and fulminant hepatic failure. J Clin Gastroenterol 1990; 12: 441-446.
54. Sile CC, Perry DJ, Nam L. Small cell carcinocythemia. Arch Pathol Lab Med 1999; 123:426-428.
55. Hubscher SG, Lumley MA, Elias E. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma. Hepatology 1993; 17:70-77.
56. Woolf GM, Vierling JM. Disappearing intrahepatic bile ducts: the syndromes and their mechanisms. Semin Liver Dis 1993; 13:261-275.
57. Nakagawa K, Miller FN, Sims DE, Leutsch AB, Miyazaki M, Edwards MJ. Mechanisms of interleukin-2-induced hepatic toxicity. Cancer Res 1996; 56:507-510.